Aktiv
BlueWillow Biologics
NanoVax intranasal vaccine platform
Hersteller
- Land
- Czechia
- Gegründet
- 2000
- Hauptsitz Stadt
- —
- Hauptsitz Adresse
- 1450 N. Dixboro Road, Ann Arbor, MI 48105, USA
- info@bluewillow.com
- Telefon
- +1 (734) 887-6040
- Website
- https://bluewillow.com/
Über uns
BlueWillow Biologics, established as NanoBio in 2000, develops intranasal vaccines using the NanoVax platform for respiratory and sexually transmitted infections, advancing candidates into clinical trials.
Impfstoffe
Keine Daten verfügbar
FAQ
Keine FAQ verfügbar.